Independent. Sources linked. No ad trackers.
Trial finder

Find a metronomic therapy clinical trial

316 trials tracked from ClinicalTrials.gov. 65 are recruiting or about to start.

Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026

A listed trial is not a recommendation, and each trial has its own eligibility rules. Your oncologist can tell you whether a trial fits your situation. Not medical advice.

316 trials shown
TrialStatusPhaseConditionsCountriesLast update
Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid TumorsNCT02897986 · Assistance Publique Hopitaux De MarseilleRecruitingPhase 1Pediatric CancerFrance2026-11-12
Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and EpendymomaNCT06485908 · Assistance Publique Hopitaux De MarseilleRecruitingPhase 1, Phase 2Medulloblastoma, EpendymomaFrance2026-11-12
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (POLF) for Resectable Locally Advanced Gastric CancerNCT06054906 · Huashan HospitalRecruitingPhase 2Gastric CancerChina2026-11-10
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal CancersNCT06425133 · Centre Hospitalier Universitaire de BesanconRecruitingPhase 2Metastatic Colorectal CancerFrance2026-11-04
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationNCT06942039 · C17 CouncilRecruitingEarly phase 1CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor, and 11 moreCanada2026-11-02
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerNCT05106296 · Theodore S. JohnsonRecruitingPhase 1Ependymoma, Medulloblastoma, Glioblastoma, and 1 moreUnited States2026-11-02
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsNCT01356290 · Medical University of ViennaRecruitingPhase 2Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, and 1 moreAustria, Czechia, Denmark, and 5 more2026-10-13
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationNCT06997068 · Mayo ClinicRecruitingPhase 2Metastatic Oral Cavity Carcinoma, Recurrent Oral Cavity Carcinoma, Stage IVC Lip and Oral Cavity Cancer AJCC v8, and 15 moreUnited States2026-10-01
Capecitabine in Low Risk Triple Negative Breast CancerNCT06787339 · Fudan UniversityRecruitingPhase 2Breast CancerChina2026-09-28
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPNNCT07710534 · Virginia Commonwealth UniversityRecruitingPhase 2Relapsed / Refractory AML, High Risk Myelodysplastic Syndrome, High Risk Myeloproliferative NeoplasmsUnited States2026-09-21
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System TumorsNCT07243470 · Centre Leon BerardRecruitingPhase 1, Phase 2Glioma, CNS Tumor, Adult, CNS Tumor, ChildhoodFrance2026-09-14
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaNCT05698524 · University of NebraskaRecruitingPhase 1Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, and 2 moreUnited States2026-09-14
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate CancerNCT06854250 · Sun Yat-sen UniversityRecruitingPhase 2Metastatic Prostate CancerChina2026-08-28
Capecitabine in ER+/HER2-negative Breast CancerNCT07631052 · University Health Network, TorontoRecruitingPhase 2ER-positive, HER2-negative Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, and 1 moreCanada2026-08-18
Study of Letrozole in Recurrent GliomasNCT03122197 · University of CincinnatiRecruitingEarly phase 1Brain TumorUnited States2026-08-18
Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose-Finding and Expansion StudyNCT07602907 · Zhejiang Cancer HospitalRecruitingPhase 2Advanced Breast Cancer, HER2-negative Breast CancerChina2026-08-11
Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)NCT07744698 · Anhui Provincial Cancer HospitalRecruitingPhase 4Squamous Non-Small Cell Lung Cancer sqNSCLC, Extensive-stage Small Cell Lung Cancer (ES-SCLC)China2026-08-04
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsNCT02813135 · Gustave Roussy, Cancer Campus, Grand ParisRecruitingPhase 1, Phase 2Pediatric CancerDenmark, France, Italy, and 3 more2026-07-10
Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid TumorsNCT07671534 · Sarcoma Oncology Research Center, LLCRecruitingPhase 2Solid Tumor CancerUnited States2026-06-26
Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer PatientsNCT05929885 · National Cancer Centre, SingaporeRecruitingPhase 2Metastatic Pancreatic CancerSingapore2026-06-23
Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain MetastasisNCT06839560 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingPhase 2Brain Metastasis From Advanced HER2-negative Breast CancerChina2026-06-10
Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.NCT06771609 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingPhase 2Advanced Triple-negative Breast CancerChina2026-06-10
RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal CarcinomaNCT07590024 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingPhase 3Nasopharyngeal Carcinoma (NPC)China2026-06-04
Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPCNCT07618078 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingNot statedNasopharyngeal Carcinoma (NPC)China2026-06-03
Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCCNCT07177794 · Sun Yat-sen UniversityRecruitingPhase 3Esophageal Cancer, ChemoradiotherapyChina2026-04-21
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaNCT06093061 · National Cancer Centre, SingaporeRecruitingPhase 2Nasopharyngeal CarcinomaSingapore2026-04-14
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung CancerNCT07001618 · Gustave Roussy, Cancer Campus, Grand ParisRecruitingPhase 2NSCLC (Advanced Non-small Cell Lung Cancer)France2026-04-03
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)NCT05384821 · Centre Oscar LambretRecruitingPhase 1, Phase 2Wilms TumorFrance2026-03-18
Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line TreatmentNCT07467330 · Fujian Cancer HospitalRecruitingPhase 3Breast CancerChina2026-03-12
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory MelanomaNCT06771544 · University of California, IrvineRecruitingPhase 2Melanoma, Melanoma Stage III, Melanoma (Skin), and 1 moreUnited States2026-03-10
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment ResponseNCT06239727 · Sun Yat-sen UniversityRecruitingPhase 3Nasopharyngeal CarcinomaChina2026-03-06
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid TumorsNCT04469530 · Emory UniversityRecruitingPhase 2Solid TumorUnited States2026-02-27
BRE-08 Phase II Study of CMC Regimen for Early Stage Breast CancerNCT06085742 · University of Illinois ChicagoRecruitingPhase 2Breast CancerUnited States2025-12-19
Adaptive Immunotherapy for Nasopharyngeal CarcinomaNCT07154069 · Sun Yat-sen UniversityRecruitingPhase 3Nasopharyngeal Cancinoma (NPC)China2025-11-25
Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving TherapyNCT07204132 · Changhai HospitalRecruitingNot applicableBladder CancerChina2025-10-02
Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeNCT07130032 · EuroCityClinic LLCRecruitingPhase 2Metastatic Non-small Cell Lung Cancer (NSCLC), Metastatic Cutaneous MelanomaRussia2025-08-19
Steps Against the Burden of Parkinson's Disease - TelAviv/BolognaNCT07105787 · University of KielRecruitingNot applicableParkinson Disease, FallsIsrael, Italy2025-08-06
Steps Against the Burden of Parkinson's Disease - RCT KielNCT07058285 · University of KielRecruitingNot applicableParkinson Disease, FallGermany2025-07-10
Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung CancerNCT07041320 · Anhui Chest HospitalRecruitingNot statedLung Cancer (NSCLC), Elderly (People Aged 65 or More)China2025-06-27
AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic TherapyNCT06494995 · Fudan UniversityRecruitingPhase 2Head and Neck Squamous Cell CarcinomaChina2025-06-04
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue SarcomaNCT04535271 · Sarcoma Oncology Research Center, LLCRecruitingPhase 2LeiomyosarcomaUnited States2025-02-24
Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei PatientsNCT06800391 · Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruitingPhase 2Pseudomyxoma PeritoneiItaly2025-01-30
Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBCNCT06700382 · Shu WangRecruitingNot statedTriple Negative Breast CancerChina2024-11-25
Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast CancerNCT03971045 · European Institute of OncologyRecruitingPhase 2Breast Cancer, Chest Wall TumorItaly2024-11-19
Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe StudyNCT05554003 · European Institute of OncologyRecruitingPhase 2Neuroendocrine Tumors, Frailty, Chemotherapy EffectItaly2024-11-18
A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart DiseaseNCT06681506 · Shanghai 10th People's HospitalRecruitingNot applicableIschemic Heart Disease, Cardiac RehabilitationChina2024-11-08
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast CancerNCT05063136 · Henan Cancer HospitalRecruitingPhase 3Breast CancerChina2024-11-04
tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)NCT05517135 · National Cancer Centre, SingaporeRecruitingNot statedNasopharyngeal CarcinomaSingapore2024-09-19
Metronomic Capecitabine in Stage III Gastric CancerNCT06313567 · Fudan UniversityRecruitingPhase 3Gastric CancerChina2024-07-08
Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of LifeNCT06381726 · University of MilanRecruitingNot applicableGlioma, Glioma, MalignantItaly2024-04-24
A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal CarcinomaNCT05940441 · Eye & ENT Hospital of Fudan UniversityRecruitingNot statedto Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal CarcinomaChina2023-07-11
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal CarcinomaNCT05342792 · Sun Yat-sen UniversityRecruitingPhase 3Nasopharyngeal CarcinomaChina2022-04-25
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTientsNCT03561740 · Sun Yat-sen UniversityRecruitingPhase 3Breast CancerChina2018-07-26
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of RecurrenceNCT02446431 · Miller Children's & Women's Hospital Long BeachRecruitingEarly phase 1Solid TumorUnited States2015-05-18
Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AMLNCT07867626 · Rutgers, The State University of New JerseyNot yet recruitingPhase 2Acute Myeloid Leukaemia (AML)United States2026-10-09
Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/GlioblastomaNCT07859059 · University of NebraskaNot yet recruitingPhase 1, Phase 2High Grade Glioma, Glioblastoma, GliosarcomaUnited States2026-10-05
Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung CancerNCT07698054 · Henan Cancer HospitalNot yet recruitingPhase 2SCLC, Extensive Stage, Bayesian, Metronomic ChemotherapyNot listed2026-07-13
Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast CancerNCT07589972 · Tianjin Medical University Cancer Institute and HospitalNot yet recruitingNot applicableNeoadjuvant Therapy in Elderly HER2-Positive Breast CancerNot listed2026-05-15
Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNCT07361133 · National Cancer Institute, EgyptNot yet recruitingPhase 2Squamous Cell Carcinoma, Advanced Head and Neck CancerEgypt2026-04-16
Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal CancerNCT07489300 · Second Affiliated Hospital, Zhejiang University, School of MedicineNot yet recruitingPhase 2Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal CancerNot listed2026-03-24
A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast CancerNCT07441486 · Tianjin Medical University Cancer Institute and HospitalNot yet recruitingPhase 2Breast CancerNot listed2026-03-02
Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast CancerNCT07019337 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesNot yet recruitingPhase 2HER2-positive Breast Cancer, Metastatic Breast CancerNot listed2025-06-13
Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic CancerNCT06759090 · Zhejiang UniversityNot yet recruitingPhase 2Metastatic Pancreatic CarcinomaChina2025-01-06
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerNCT06229067 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesNot yet recruitingPhase 2Breast Cancer, Triple Negative Breast CancerNot listed2024-01-29
Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast CancerNCT05172518 · Sun Yat-sen UniversityNot yet recruitingPhase 3Breast Neoplasms, Locally Advanced or Metastatic Breast CancerChina2021-12-29
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).NCT06217185 · Hebei Medical University Fourth HospitalActive, not recruitingPhase 4HER2-positive Breast Cancer, Advanced Breast CancerChina2026-11-10
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal CancerNCT05462613 · Centre Hospitalier Universitaire de BesanconActive, not recruitingPhase 2, Phase 3Metastatic Colorectal CancerFrance2026-11-04
Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPGNCT04049669 · Theodore S. JohnsonActive, not recruitingPhase 2Glioblastoma, Medulloblastoma, Ependymoma, and 1 moreUnited States2026-11-02
Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk NeuroblastomaNCT01192555 · Baylor College of MedicineActive, not recruitingPhase 1, Phase 2NeuroblastomaUnited States2026-10-02
Bevacizumab/Doxorubicin/Radiation for SarcomaNCT01746238 · Massachusetts General HospitalActive, not recruitingPhase 1SarcomaUnited States2026-09-08
Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaNCT06712888 · Sun Yat-sen UniversityActive, not recruitingPhase 3Nasopharyngeal Carcinoma (NPC)China2026-08-13
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsNCT02574728 · Emory UniversityActive, not recruitingPhase 2CancerUnited States2026-03-02
Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPCNCT07248670 · Chongqing University Cancer HospitalActive, not recruitingPhase 3Nasopharyngeal Cancinoma (NPC)China2025-11-25
Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas CancerNCT01088789 · Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsActive, not recruitingPhase 2Pancreatic CancerUnited States2025-08-26
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate CancerNCT05479578 · Rashmi Verma, MDActive, not recruitingPhase 1Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) V8United States2025-01-08
DPX-Survivac and Checkpoint Inhibitor in DLBCLNCT03349450 · Sunnybrook Health Sciences CentreCompletedPhase 2Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory Diffuse Large B-Cell LymphomaCanada2026-09-25
Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative CancerNCT00420563 · Centre Oscar LambretCompletedPhase 2CancerFrance2026-09-17
Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib MesylateNCT01046487 · Centre Oscar LambretCompletedPhase 1CancerFrance2026-09-17
Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived ExosomesNCT01159288 · Gustave Roussy, Cancer Campus, Grand ParisCompletedPhase 2Non Small Cell Lung CancerFrance2026-08-17
Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung CancerNCT03801304 · University Hospital, BrestCompletedPhase 2Non-small Cell Lung CancerFrance2026-06-30
Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsNCT02755844 · Hospices Civils de LyonCompletedPhase 1, Phase 2Recurrent Endometrial CancerFrance2026-05-27
Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric CancerNCT04984733 · University of SouthamptonCompletedPhase 2Adenocarcinoma - GEJ, Cancer of EsophagusUnited Kingdom2026-05-18
Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly PaclitaxelNCT01374620 · Centre Oscar LambretCompletedPhase 1CancerFrance2026-03-16
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast CancerNCT02767661 · Sun Yat-sen UniversityCompletedPhase 3Breast CancerChina2026-02-27
Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic CyclophosphamideNCT02805725 · Institut BergoniéCompletedPhase 1, Phase 2Soft-tissue SarcomasFrance2026-01-14
Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II TrialNCT02406781 · Institut BergoniéCompletedPhase 2SarcomaFrance2025-12-10
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple MyelomaNCT02412228 · John L. ReaganCompletedPhase 2Multiple MyelomaUnited States2025-10-15
Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior BevacizumabNCT01931098 · National Cancer Institute (NCI)CompletedPhase 2Glioblastoma, Glioblastoma Multiforme, Gliosarcoma, and 2 moreUnited States2025-08-11
Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated OsteosarcomaNCT02517918 · Institut BergoniéCompletedPhase 1Solid Tumor, OsteosarcomaFrance2025-06-08
A Study of Different Dosing Schedules of Selinexor in Sarcoma PatientsNCT04811196 · University Health Network, TorontoCompletedPhase 1Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma, and 1 moreCanada2025-05-29
Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid TumoursNCT03518606 · UNICANCERCompletedPhase 1, Phase 2Advanced Solid Tumours, Breast Cancer, Head and Neck Cancer, and 2 moreFrance2025-01-15
Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine TumorsNCT02736500 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSCompletedPhase 1, Phase 2Neuroendocrine Tumors, Gastro Entero Pancreatic Neuroendocrine TumorsItaly2025-01-13
Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal CancerNCT04534218 · Centre Hospitalier Universitaire de BesanconCompletedPhase 2Colo-rectal Cancer, Metastatic CancerFrance2024-12-20
Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGGNCT03879512 · Wuerzburg University HospitalCompletedPhase 1, Phase 2Childhood GlioblastomaGermany2024-09-19
Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk NeuroblastomaNCT02641314 · University of CologneCompletedPhase 2Recurrent NeuroblastomaGermany2024-05-10
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer PatientsNCT06373744 · Sun Yat-sen UniversityCompletedNot statedBreast CancerChina2024-04-18
MEtronomic TrEatment Option in Advanced bReast cAncerNCT02954055 · ETOP IBCSG Partners FoundationCompletedPhase 2Breast CancerItaly2024-02-26
Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer PatientsNCT02583828 · Capital Medical UniversityCompletedNot applicableBreast Neoplasms, Neoplasm MetastasisChina2024-02-07
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid TumorsNCT01661400 · Washington University School of MedicineCompletedPhase 1Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor, and 4 moreUnited States2024-01-31
Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and SafetyNCT06216990 · Centre Hospitalier Universitaire de BesanconCompletedNot statedSarcoma, Soft Tissue SarcomaNot listed2024-01-22
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' ResistanceNCT06202599 · Peking University People's HospitalCompletedNot statedBone Sarcoma, Soft Tissue Sarcoma, Refractory TumorChina2024-01-17
Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast CancerNCT04350021 · Vastra Gotaland RegionCompletedNot statedBreast Cancer Metastatic, Chemotherapy EffectSweden2024-01-17
Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLCNCT02709720 · Spanish Lung Cancer GroupCompletedPhase 2Lung CancerSpain2024-01-11
Racotumomab in Patients With High-risk NeuroblastomaNCT02998983 · Laboratorio Elea Phoenix S.A.CompletedPhase 2NeuroblastomaArgentina2023-09-11
N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk NeuroblastomaNCT00885326 · New Approaches to Neuroblastoma Therapy ConsortiumCompletedPhase 1NeuroblastomaCanada, United States2023-04-10
A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.NCT01285817 · Assistance Publique Hopitaux De MarseilleCompletedPhase 2Survival Without ProgressionFrance2023-03-13
Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesNCT01015222 · M.D. Anderson Cancer CenterCompletedPhase 1Advanced CancerUnited States2022-11-23
Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPMNCT02555007 · Assistance Publique Hopitaux De MarseilleCompletedPhase 1Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM)France2022-11-17
Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1NCT01597414 · European Organisation for Research and Treatment of Cancer - EORTCCompletedPhase 2Elderly Metastatic Breast Cancer PopulationBelgium, France, Italy, and 5 more2022-11-17
Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid TumoursNCT02303028 · The Hospital for Sick ChildrenCompletedPhase 1, Phase 2Solid TumorsCanada2022-06-28
Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell LymphomasNCT03161054 · Fondazione Italiana Linfomi - ETSCompletedPhase 2Aggressive Non-Hodgkin LymphomaItaly2021-12-20
Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT02853318 · Roswell Park Cancer InstituteCompletedPhase 2Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, and 11 moreUnited States2021-10-06
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent GlioblastomaNCT02770378 · University of UlmCompletedPhase 1, Phase 2GlioblastomaGermany2021-10-05
Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic CyclophosphamideNCT03139851 · Centre Leon BerardCompletedPhase 2Metastatic Breast CancerFrance2021-09-10
Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine TumorsNCT02838342 · Centre Hospitalier Universitaire de BesanconCompletedPhase 2Neuroendocrine TumorsFrance2021-08-02
OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic AdenocarcinomaNCT02368860 · National Cancer Centre, SingaporeCompletedPhase 1Pancreatic CancerSingapore2021-06-01
Temozolomide for Second-Line Treatment of Neuroendocrine CarcinomasNCT04122911 · National Cancer Institute, NaplesCompletedPhase 2Neuroendocrine CarcinomasItaly2020-10-26
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk NeuroblastomaNCT01467986 · University of RegensburgCompletedPhase 2Neuroblastoma RecurrentGermany2020-10-06
Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsNCT00390156 · University of California, San FranciscoCompletedPhase 1Unspecified Adult Solid TumorUnited States2020-07-28
Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast CancerNCT01908101 · University of WashingtonCompletedPhase 2Recurrent Breast Carcinoma, Stage IV Breast CancerUnited States2020-07-23
Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer PatientsNCT04425564 · National Cancer Institute, EgyptCompletedPhase 2Clinical Response, Toxicity, SurvivalNot listed2020-06-11
Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsNCT01331135 · Emory UniversityCompletedPhase 1Ewing's Sarcoma, Osteosarcoma, Astrocytoma, and 13 moreUnited States2020-05-29
Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast CancerNCT01112826 · Sun Yat-sen UniversityCompletedPhase 3Breast CancerChina2020-05-27
Protracted Etoposide During Induction Therapy for High Risk NeuroblastomaNCT00578864 · Baylor College of MedicineCompletedPhase 2NeuroblastomaUnited States2020-03-27
Dose-finding Study of BP-C1 in Patients With Stage IV Breast CancerNCT04298333 · Meabco A/SCompletedPhase 1Metastatic Breast Cancer, Stage IV Breast CancerIndonesia, Taiwan, Thailand2020-03-06
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by SurgeryNCT00727441 · Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsCompletedPhase 2Pancreatic CancerUnited States2020-02-25
Low Dose Metronomic Poly-chemotherapy for Metastatic CRCNCT02280694 · HaEmek Medical Center, IsraelCompletedPhase 2Colorectal CancerIsrael2020-02-12
Vaccination in Prostate Cancer (VANCE)NCT02390063 · University of OxfordCompletedPhase 1Prostate CancerUnited Kingdom2020-02-10
ABT-888 Plus Metronomic Cyclophosphamide to Treat CancerNCT01445522 · National Cancer Institute (NCI)CompletedPhase 1Neoplasms, LymphomaUnited States2019-12-17
Phase I Clinical Trial of Cryoimmunotherapy Against Prostate CancerNCT02423928 · Alden Cancer Therapy IICompletedPhase 1Prostate CancerNorway2019-10-25
Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic CancerNCT02620800 · CelgeneCompletedPhase 1Metastatic Pancreas AdenocarcinomaUnited States2019-10-22
BP-C1 in Short-term Treatment of Patients With Metastatic Breast CancerNCT02783794 · Meabco A/SCompletedPhase 2Metastatic Breast Cancer, Stage IV Breast CancerRussia, Thailand2019-10-10
BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of TreatmentNCT03789019 · Meabco A/SCompletedPhase 2Metastatic Breast Cancer, Stage IV Breast CancerRussia, Thailand2019-10-10
BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast CancerNCT03603197 · Meabco A/SCompletedPhase 2Metastatic Breast Cancer, Stage IV Breast CancerThailand2019-10-07
BP-C1 in Metastatic Breast Cancer PatientsNCT01861509 · Meabco A/SCompletedPhase 1Metastatic Breast Cancer, Stage IV Breast CancerIsrael, Thailand2019-10-07
Cyclophosphamide for Nasopharyngeal CarcinomaNCT02794077 · The University of Hong KongCompletedPhase 2Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Undifferentiated CarcinomaNot listed2019-10-02
Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck CancerNCT01581970 · Masonic Cancer Center, University of MinnesotaCompletedPhase 2Head and Neck Cancer, Head and Neck Squamous Cell CarcinomaUnited States2019-09-11
Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast CancerNCT03007992 · Johannes Gutenberg University MainzCompletedPhase 2Metastatic Breast CancerGermany2019-08-12
Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian CancerNCT01610869 · University College, LondonCompletedPhase 2Ovarian Cancer, Fallopian Tube CancerUnited Kingdom2019-05-29
Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast CancerNCT00083031 · Dana-Farber Cancer InstituteCompletedPhase 2Breast CancerUnited States2019-05-21
Metronomic Therapy in Metastatic Breast Cancer.NCT01131195 · Swiss Cancer InstituteCompletedPhase 3Breast CancerSwitzerland2019-05-15
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA TrialNCT02176369 · Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoCompletedPhase 2Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IVItaly2019-04-22
Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine TumorsNCT00605566 · University Health Network, TorontoCompletedPhase 2Neuroendocrine TumorsCanada2019-02-19
BP-C1 in Short-term Treatment of Metastatic Pancreatic CancerNCT03627390 · Meabco A/SCompletedPhase 2Metastatic Pancreatic Cancer, Unresectable Pancreatic CancerEgypt2018-11-15
Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)NCT02802748 · SOLTI Breast Cancer Research GroupCompletedEarly phase 1Breast CancerSpain2018-09-20
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/GlioblastomaNCT00200161 · Memorial Sloan Kettering Cancer CenterCompletedPhase 2Glioblastoma, GliomasUnited States2018-03-07
Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast CancerNCT02664103 · SanofiCompletedPhase 2Breast Cancer MetastaticIndia2018-02-01
Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast CancersNCT01843725 · Jules Bordet InstituteCompletedPhase 1Metastatic Colorectal Cancers, Metastatic Gastric Cancers, Metastatic Oesophageal Cancers, and 3 moreBelgium2018-01-31
Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal CancerNCT02271464 · Azienda Ospedaliero, Universitaria PisanaCompletedPhase 2Metastatic Colorectal CancerItaly2017-12-07
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerNCT00287885 · Masonic Cancer Center, University of MinnesotaCompletedPhase 1Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, and 5 moreNot listed2017-11-29
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung CancerNCT00655850 · University of Alabama at BirminghamCompletedPhase 2Non-Small Cell Lung CancerUnited States2017-07-17
Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDSNCT00744536 · Sunnybrook Health Sciences CentreCompletedPhase 2Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, AngiogenesisCanada2017-06-09
Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell CancerNCT01462214 · Hans J. van der Vliet, MD, PhDCompletedPhase 1, Phase 2Metastatic Renal Cell CancerNetherlands2017-05-10
Phase II ABT-888 With CyclophosphamideNCT01306032 · National Cancer Institute (NCI)CompletedPhase 2Ovarian Cancer, Primary Peritoneal Cancer, Serous Carcinoma Cancer, and 2 moreCanada, United States2017-04-26
Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced SarcomasNCT01716689 · National Cancer Centre, SingaporeCompletedPhase 2SarcomaSingapore2017-03-29
Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic TumorsNCT00800345 · Vector OncologyCompletedPhase 1Gynecologic TumorsUnited States2017-03-28
A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or TaxanesNCT01589159 · Tao OUYANGCompletedPhase 2Metastatic Breast CancerChina2017-02-27
Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric MalignanciesNCT01858571 · All India Institute of Medical SciencesCompletedPhase 3Malignant Childhood NeoplasmIndia2017-01-25
Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate CancerNCT00427999 · Novartis PharmaceuticalsCompletedPhase 2Prostate CancerGermany2016-11-21
Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast CancerNCT01941771 · University of AarhusCompletedPhase 2Breast CancerDenmark2016-10-28
ONCOS-102 (Previously CGTG-102) for Therapy of Advanced CancersNCT01598129 · Targovax OyCompletedPhase 1Malignant Solid TumourFinland2016-10-24
Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung CancerNCT00755170 · Hellenic Oncology Research GroupCompletedPhase 2Non Small Cell Lung CancerGreece2016-10-04
Relapse Myeloma; Cyclofosfamide; Bortezomib; MaintenanceNCT02467010 · University Medical Center GroningenCompletedPhase 2Multiple MyelomaNetherlands2015-06-09
Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.NCT01229813 · Lund University HospitalCompletedPhase 3Colorectal CancerDenmark, Sweden2015-04-13
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive CancerNCT00357500 · Dana-Farber Cancer InstituteCompletedPhase 2Central Nervous System Tumor, Pediatric, Leukemia, Lymphoma, and 3 moreUnited States2014-10-01
Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate CancerNCT00176605 · Rutgers, The State University of New JerseyCompletedPhase 2Prostate CancerUnited States2014-05-20
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast CancerNCT00121134 · Harold J. Burstein, MD, PhDCompletedNot applicableBreast CancerUnited States2013-12-24
ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast CancerNCT00496665 · Dana-Farber Cancer InstituteCompletedPhase 1Metastatic Breast CancerUnited States2013-11-18
Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerNCT00870532 · National Cancer Centre, SingaporeCompletedPhase 1Non-Small Cell Lung CancerSingapore2013-11-04
Oral Topotecan to Treat Recurrent or Persistent Solid TumorsNCT00382733 · Accelerated Community Oncology Research NetworkCompletedPhase 1, Phase 2TumorsUnited States2013-07-22
Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant GliomaNCT00501891 · Duke UniversityCompletedPhase 2Glioblastoma MultiformeUnited States2013-05-27
A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal CancerNCT00683241 · Abramson Cancer Center at Penn MedicineCompletedPhase 1Ovarian Cancer, Peritoneal CancerUnited States2013-02-26
Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung CancerNCT00702182 · National Cancer Centre, SingaporeCompletedPhase 1Non-Small Cell Lung CancerSingapore2012-10-19
Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12NCT00194753 · University of WashingtonCompletedPhase 2Breast NeoplasmUnited States2012-09-13
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00083161 · Gundersen Lutheran Health SystemCompletedPhase 2Lung CancerUnited States2012-09-05
A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine GliomasNCT00036569 · National Cancer Institute (NCI)CompletedPhase 2Diffuse Intrinsic Pontine GliomaUnited States2012-02-13
Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced NeoplasmNCT00908869 · Institut Paoli-CalmettesCompletedPhase 1Advanced NeoplasmFrance2012-01-30
UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaNCT00519688 · National Taiwan University HospitalCompletedPhase 2Hepatocellular CarcinomaTaiwan2011-10-17
5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine TumorsNCT00953394 · University of Turin, ItalyCompletedPhase 2Neuroendocrine TumorsItaly2009-08-06
Metronomic Oral Vinorelbine in Patients With Metastatic TumorsNCT00278070 · Hellenic Cooperative Oncology GroupCompletedPhase 2Breast Cancer, Non Small Cell Lung Cancer, Prostate CancerGreece2008-02-29
Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma PatientsNCT04757337 · UNICANCERStatus unknownPhase 3Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue SarcomaFrance2025-03-25
Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.NCT06857747 · QIAO LIStatus unknownNot applicableBreast CancerNot listed2025-03-04
Phase I Trial: T4 Immunotherapy of Head and Neck CancerNCT01818323 · King's College LondonStatus unknownPhase 1Head and Neck CancerUnited Kingdom2024-10-09
GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced SarcomaNCT04535713 · Sarcoma Oncology Research Center, LLCStatus unknownPhase 2SarcomaUnited States2024-07-05
Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLCNCT06260553 · Fujian Cancer HospitalStatus unknownPhase 2EGFR/ ALK-negative Advanced NSCLCChina2024-02-15
Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer PatientsNCT06015126 · Yan XueStatus unknownNot applicableBreast CancerChina2023-08-29
Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer PatientsNCT04304352 · European Institute of OncologyStatus unknownPhase 2Advanced Breast CancerItaly2023-06-28
EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)NCT04072107 · Sun Yat-sen UniversityStatus unknownPhase 2Nasopharyngeal CarcinomaChina2023-06-18
Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast CancerNCT04942899 · Assiut UniversityStatus unknownPhase 2Metastasis BreastNot listed2023-03-01
Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast CancerNCT05747326 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesStatus unknownPhase 2Breast CancerChina2023-02-28
Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast CancerNCT05747313 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesStatus unknownPhase 1, Phase 2Breast Cancer, Chemotherapy EffectChina2023-02-28
Almonertinib Plus Metronomic Oral VinorelbineNCT05663177 · Fujian Cancer HospitalStatus unknownNot statedEGFR, NSCLC, Third-generation TKINot listed2022-12-23
Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.NCT05411380 · wang shusenStatus unknownPhase 2Breast CancerChina2022-11-04
Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical TrialNCT05390476 · wang shusenStatus unknownPhase 2Triple Negative Breast CancerChina2022-11-04
Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)NCT05603013 · Second Affiliated Hospital of Soochow UniversityStatus unknownPhase 2Carcinoma, Non-Small-Cell Lung, Carcinoma BreastChina2022-11-02
Metronomic PLD in Patients With Primary Endocrine Resistant ABCNCT03071926 · Fudan UniversityStatus unknownPhase 2Advanced Breast CancerChina2022-04-20
Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal CarcinomaNCT04921995 · Fudan UniversityStatus unknownPhase 2Recurrent Nasopharyngeal Carcinoma, Unresectable Nasopharyngeal Carcinoma, Chemotherapy Effect, and 2 moreChina2022-04-04
Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) PatientsNCT02499367 · The Netherlands Cancer InstituteStatus unknownPhase 2Breast CancerNetherlands2022-03-22
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)NCT05044117 · Sun Yat-sen UniversityStatus unknownPhase 3Head and Neck Squamous Cell CarcinomaChina2022-03-03
Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic VinorelbineNCT04389073 · Cancer Institute and Hospital, Chinese Academy of Medical SciencesStatus unknownPhase 2Metastatic Breast CancerChina2022-02-25
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)NCT02630368 · Institut BergoniéStatus unknownPhase 1, Phase 2Solid Tumors, Soft-tissue Sarcoma, Breast CancerFrance2022-02-02
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3)NCT04932187 · Ruijin HospitalStatus unknownPhase 1Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi)China2021-09-17
Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast CancerNCT04941885 · Sun Yat-sen UniversityStatus unknownPhase 2Breast CancerChina2021-07-02
Metronomic Chemotherapy With Capecitabine for Pancreatic CancerNCT03959150 · Ruijin HospitalStatus unknownPhase 2, Phase 3Pancreatic CancerChina2021-04-30
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)NCT04508686 · Ruijin HospitalStatus unknownPhase 1Advanced Cervical CancerChina2021-01-29
ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based TreatmentsNCT04212702 · National Taiwan University HospitalStatus unknownNot statedMetastatic Breast CancerTaiwan2021-01-12
Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)NCT04571437 · Cairo UniversityStatus unknownPhase 2Breast Cancer, Estrogen Receptor-positive Breast Cancer, Metastatic Breast CancerEgypt2020-10-01
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)NCT04510818 · Ruijin HospitalStatus unknownPhase 1Head and Neck Cancer, Esophageal Squamous CancerChina2020-08-14
Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBCNCT01917279 · Binghe XuStatus unknownPhase 3Breast Neoplasms, Neoplasms by Site, Neoplasm Metastasis, and 2 moreChina2020-07-23
Targeting the Tumor Microenvironment in R/M SCCHNNCT03844763 · Gruppo Oncologico del Nord-OvestStatus unknownPhase 1, Phase 2Head and Neck CancerItaly2020-03-03
Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)NCT04208854 · International Group of Endovascular OncologyStatus unknownNot statedLocally Advanced/ Metastatic NSCLCItaly2019-12-26
Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast CancerNCT03923166 · Chinese Academy of Medical SciencesStatus unknownPhase 2Breast CancerChina2019-04-22
MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerNCT02007148 · International Group of Endovascular OncologyStatus unknownPhase 2Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaItaly2019-02-27
A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast CancerNCT03854617 · Chinese Academy of Medical SciencesStatus unknownPhase 2Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNot listed2019-02-26
A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade GliomasNCT02209428 · Huashan HospitalStatus unknownPhase 2Astrocytoma, Oligodendroglioma, OligoastrocytomaChina2019-02-21
Endothelial Progenitor Cells in Cervical Cancer Patients Receiving ChemoradiationNCT00753610 · Mackay Memorial HospitalStatus unknownNot statedCervical CancerTaiwan2018-08-17
Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast CancerNCT03507465 · Guangdong Provincial People's HospitalStatus unknownPhase 2, Phase 3Breast CancerChina2018-04-25
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian CancerNCT01650376 · Swedish Medical CenterStatus unknownPhase 1, Phase 2Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Uterine CancerUnited States2018-03-23
A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLCNCT02852083 · University Hospital RegensburgStatus unknownPhase 2Squamous Cell Lung Cancer, Non-Squamous Cell Lung Cancer, Non-Small Cell Lung CancerGermany2018-01-18
Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic OsteosarcomaNCT03063983 · Grupo de Apoio ao Adolescente e a Crianca com CancerStatus unknownPhase 2OsteosarcomaBrazil2017-03-13
Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRCNCT02893540 · Ruijin HospitalStatus unknownPhase 2, Phase 3Colorectal CancerChina2016-09-16
A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon CancerNCT02887365 · National Taiwan University HospitalStatus unknownPhase 4MSI-L/MSS, Stage II Colon CancerTaiwan2016-09-07
Metronomic Chemotherapy in Advanced Gastric CancerNCT02855788 · Huashan HospitalStatus unknownPhase 2Metastatic Gastric Cancer, Locally Advanced Gastric CancerChina, United States2016-08-04
Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)NCT02732678 · Assistance Publique Hopitaux De MarseilleStatus unknownPhase 1, Phase 2AngiosarcomaFrance2016-04-11
Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the ExtremityNCT02273583 · Grupo de Apoio ao Adolescente e a Crianca com CancerStatus unknownPhase 2High Grade OsteosarcomaBrazil2016-02-11
Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal CancerNCT02575378 · Ruijin HospitalStatus unknownPhase 4Metastatic Colorectal CancerNot listed2015-10-14
Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast CancerNCT02012634 · Xijing HospitalStatus unknownNot statedBreast Cancer, Capecitabine, Triple Negative Breast CancerChina2014-11-13
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerNCT00553683 · Rutgers, The State University of New JerseyStatus unknownPhase 1, Phase 2Breast Cancer, Colorectal Cancer, Gastric Cancer, and 5 moreUnited States2014-01-14
Maintenance Treatment Versus Observation After Induction in Advanced Colorectal CarcinomaNCT00442637 · Dutch Colorectal Cancer GroupStatus unknownPhase 3Colorectal Cancer MetastaticNetherlands2013-12-12
Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung CarcinomaNCT01947062 · Swami Rama Cancer Hospital and Research InstituteStatus unknownPhase 3Lung Cancer, Squamous Cell Carcinoma of the Lung, Locally Advanced and Metastatic Squamous Cell Carcinoma of the LungIndia2013-09-20
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerNCT01924078 · Fudan UniversityStatus unknownPhase 2Breast CancerChina2013-08-16
Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)NCT00204568 · University Hospital Schleswig-HolsteinStatus unknownPhase 2Sarcoma, Soft TissueGermany2013-01-08
Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced MelanomaNCT01614301 · University of RegensburgStatus unknownPhase 1, Phase 2Advanced MelanomaGermany2012-06-07
Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant ChemotherapyNCT01612247 · University of VermontStatus unknownNot applicableBreast CancerUnited States2012-06-05
Third-line Therapy of Multiple Myeloma a Prospective Phase I /II TrialNCT01010243 · University of RegensburgStatus unknownPhase 1, Phase 2Multiple MyelomaGermany2012-05-30
Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic CancerNCT00082862 · The University of Texas Health Science Center, HoustonStatus unknownPhase 2Pancreatic CancerUnited States2012-02-13
Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast CancerNCT01526499 · Fudan UniversityStatus unknownPhase 2Breast CancerChina2012-02-07
Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast CancerNCT01526512 · Fudan UniversityStatus unknownPhase 2Breast CancerChina2012-02-07
Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell CarcinomaNCT00855881 · Mackay Memorial HospitalStatus unknownPhase 2Head and Neck CancerTaiwan2011-07-26
Metronomic Temozolamide in Patients With Recurrent GlioblastomaNCT01308632 · Grupo Español de Investigación en NeurooncologíaStatus unknownPhase 2, Phase 3GlioblastomaNot listed2011-03-04
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsNCT00178698 · The University of Texas Health Science Center, HoustonStatus unknownPhase 2Neuroendocrine Cancer, Small Cell Lung Cancer, Non-Small Cell Lung Cancer, and 1 moreUnited States2011-03-03
Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas CancerNCT00178763 · The University of Texas Health Science Center, HoustonStatus unknownPhase 2Pancreatic NeoplasmsUnited States2011-03-03
Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine TumorsNCT01203306 · University of Turin, ItalyStatus unknownPhase 2Neuroendocrine CarcinomasItaly2010-09-16
Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer PatientsNCT00954135 · University of Turin, ItalyStatus unknownPhase 2Breast CancerItaly2009-08-07
Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerNCT00687648 · National Cancer Centre, SingaporeStatus unknownPhase 2Breast CancerSingapore2009-06-17
Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal CancerNCT00890188 · National Cheng-Kung University HospitalStatus unknownPhase 2Colon CancerTaiwan2009-05-07
Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer PatientsNCT00786110 · University of Turin, ItalyStatus unknownPhase 2Adrenocortical CarcinomaItaly2009-02-24
Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic MalignanciesNCT00641160 · Metronome TherapeuticsStatus unknownPhase 1Nonhematologic MalignanciesUnited States2008-09-26
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerNCT00323583 · Seattle Cancer Treatment and Wellness CenterStatus unknownPhase 2Adenocarincoma of Pancreas, Stage III Pancreatic Cancer, Stage IVA Pancreatic Cancer, and 1 moreUnited States2007-05-08
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast CancerNCT02897050 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuspendedPhase 2Breast CancerChina2022-04-20
Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsNCT03585465 · Centre Oscar LambretTerminatedPhase 1, Phase 2Childhood Solid TumorBelgium, France2026-09-17
Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and GlioblastomaNCT02942264 · National Cancer Institute (NCI)TerminatedPhase 1, Phase 2Brain Tumor, Astrocytoma, Astroglioma, and 2 moreUnited States2026-02-23
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyNCT03329248 · ImmunityBio, Inc.TerminatedPhase 1, Phase 2Pancreatic CancerUnited States2024-12-12
QUILT-3.080: NANT Pancreatic Cancer VaccineNCT03586869 · ImmunityBio, Inc.TerminatedPhase 1, Phase 2Pancreatic CancerUnited States2024-08-27
QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.NCT03387085 · ImmunityBio, Inc.TerminatedPhase 1, Phase 2Triple Negative Breast CancerUnited States2024-08-09
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have ProgressedNCT03387111 · ImmunityBio, Inc.TerminatedPhase 1, Phase 2Squamous Cell CarcinomaUnited States2024-08-05
Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly PatientsNCT04656262 · Istituto Oncologico Veneto IRCCSTerminatedPhase 3Soft Tissue Sarcoma AdultItaly2024-07-08
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyNCT03136406 · ImmunityBio, Inc.TerminatedPhase 1, Phase 2Pancreatic CancerUnited States2024-06-11
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyNCT03387098 · ImmunityBio, Inc.TerminatedPhase 1, Phase 2Pancreatic CancerUnited States2024-05-22
A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue SarcomaNCT04780464 · European Organisation for Research and Treatment of Cancer - EORTCTerminatedPhase 3Advanced Soft-tissue SarcomaCyprus, Jordan2024-02-22
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade GliomaNCT02168270 · University of NebraskaTerminatedPhase 1Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, and 2 moreUnited States2023-11-24
T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic RadiosurgeryNCT03190967 · National Cancer Institute (NCI)TerminatedPhase 1, Phase 2Breast Cancer, Brain Metastasis, Brain CancerUnited States2023-10-11
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast CancerNCT01873833 · University of Southern CaliforniaTerminatedPhase 2HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerUnited States2023-10-05
Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.NCT02585388 · ARCAGY/ GINECO GROUPTerminatedPhase 2Breast CancerFrance2023-09-06
BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent GlioblastomaNCT03119064 · Brown UniversityTerminatedPhase 1, Phase 2Glioblastoma Multiforme, Glioblastoma, GBMUnited States2022-12-13
Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or MediastinumNCT02054104 · National Cancer Institute (NCI)TerminatedPhase 1, Phase 2Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura, and 2 moreUnited States2022-01-26
Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast CancerNCT00925652 · Dana-Farber Cancer InstituteTerminatedPhase 2Breast CancerUnited States2022-01-19
Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast CancerNCT00542191 · Leo W. Jenkins Cancer CenterTerminatedPhase 2Breast CancerUnited States2021-05-26
Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal CancerNCT03158610 · Ruijin HospitalTerminatedPhase 2, Phase 3Colorectal CancerChina2021-05-03
Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast CancerNCT00296010 · ETOP IBCSG Partners FoundationTerminatedPhase 3Breast CancerAustralia, Belgium, Hungary, and 6 more2021-02-23
A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced DiseaseNCT02730091 · Centre Hospitalier Universitaire de BesanconTerminatedPhase 3Breast CancerFrance2021-02-01
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1NCT02387125 · Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)TerminatedPhase 1Sarcoma, Melanoma, Non-small Cell Lung Cancer, and 1 moreUnited States2020-07-01
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell CancerNCT02842125 · MultiVir, Inc.TerminatedPhase 1, Phase 2Metastatic Solid Tumor Cancer, Recurrent Head and Neck CancerUnited States2020-06-02
Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung CancerNCT02985203 · Guangdong Association of Clinical TrialsTerminatedPhase 2Lung Neoplasm MalignantChina2020-03-12
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumNCT01313429 · National Cancer Institute (NCI)TerminatedPhase 1Sarcoma, Melanoma, Epithelial Malignancies, and 1 moreUnited States2020-03-03
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasNCT01143545 · National Cancer Institute (NCI)TerminatedPhase 1Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, and 2 moreUnited States2020-03-03
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung CancerNCT02117024 · Heat BiologicsTerminatedPhase 2Non Small Cell Lung CancerUnited States2020-02-05
Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and BortezomibNCT04243109 · Maimónides Biomedical Research Institute of CórdobaTerminatedPhase 2Multiple MyelomaSpain2020-01-28
Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast CancerNCT00616122 · University of California, San FranciscoTerminatedPhase 1, Phase 2Breast CancerUnited States2020-01-13
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent GlioblastomaNCT01044966 · Medical University of South CarolinaTerminatedPhase 1, Phase 2Glioblastoma Multiforme, Glioma, Astrocytoma, and 1 moreUnited States2019-02-12
Metronomic Therapy in Patients With Metastatic MelanomaNCT01542255 · Dartmouth-Hitchcock Medical CenterTerminatedPhase 2Metastatic MelanomaUnited States2019-01-15
the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line TreatmentNCT03358004 · Mario Negri Institute for Pharmacological ResearchTerminatedPhase 2Triple Negative Breast CancerItaly, Portugal, Spain2018-10-05
Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor RemovalNCT01341496 · National Cancer Institute (NCI)TerminatedPhase 1Sarcoma, Melanoma, Epithelial Malignancies, and 1 moreUnited States2018-07-05
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and TaxanesNCT01910870 · Centre Jean PerrinTerminatedPhase 2Metastatic Breast CancerFrance2018-05-18
Capecitabine With Digoxin for Metastatic Breast CancerNCT01887288 · Western Regional Medical CenterTerminatedPhase 2Metastatic Breast CancerUnited States2018-02-22
Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase ExpressionNCT02919462 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSTerminatedPhase 2Carcinoma, Non-Small-Cell Lung, Secondary, Advanced Stage IIIB, and 1 moreItaly2018-01-16
Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLCNCT00801801 · Francisco Robert,MDTerminatedPhase 2Non Squamous Cell Lung Cancer, Non Small Cell Lung CancerUnited States2017-05-17
Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaNCT00482911 · National Institutes of Health Clinical Center (CC)TerminatedPhase 2Intraocular Melanoma, Malignant Conjunctival NeoplasmUnited States2017-03-27
Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)NCT02279576 · Spanish Oncology Genito-Urinary GroupTerminatedPhase 2Penile Squamous Cell Carcinoma Stage IVSpain2016-10-14
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and TaxanesNCT01910844 · Centre Jean PerrinTerminatedPhase 2Metastatic Breast CancerFrance2016-10-11
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and NeckNCT01285635 · University of Michigan Rogel Cancer CenterTerminatedPhase 2Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States2016-03-31
Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast CancerNCT00754702 · University Hospital of CreteTerminatedPhase 2Breast CancerGreece2015-09-28
Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and AdolescentsNCT01517776 · Martin-Luther-Universität Halle-WittenbergTerminatedPhase 2GliomasGermany2015-07-21
Maintenance Metronomic Chemotherapy for Metastatic Colorectal CarcinomaNCT01668680 · HaEmek Medical Center, IsraelTerminatedPhase 2Colorectal Cancer MetastaticIsrael2015-07-08
Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerNCT01067989 · HaEmek Medical Center, IsraelTerminatedPhase 2Chemotherapy, Breast Cancer, MetastaticIsrael2015-07-08
Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment StrategyNCT01175772 · HaEmek Medical Center, IsraelTerminatedPhase 2Ovarian CarcinomaIsrael2015-06-23
Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast CancerNCT00694200 · Hellenic Oncology Research GroupTerminatedPhase 2Breast CancerGreece2015-05-29
Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast CancerNCT01262274 · Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanTerminatedPhase 2Breast NeoplasmsJapan2015-05-21
Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)NCT01329640 · Instituto do Cancer do Estado de São PauloTerminatedPhase 2Locally Advanced HER2-positive Breast CancerBrazil2014-05-21
Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast CancerNCT01329627 · Instituto do Cancer do Estado de São PauloTerminatedPhase 2Locally Advanced HER2-negative Breast CancerBrazil2014-05-21
Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerNCT00705549 · Hellenic Oncology Research GroupTerminatedPhase 2Non-Small-Cell Lung CancerGreece2013-02-13
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBMNCT00548938 · Methodist Healthcare - MemphisTerminatedPhase 2Glioblastoma Multiforme, High-Grade GliomaUnited States2009-09-18
QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLNCT03169790 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Non Hodgkin LymphomaNot listed2025-02-24
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyNCT03169764 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Head and Neck Squamous Cell CarcinomaNot listed2025-02-24
QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 TherapyNCT03167164 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Merkel Cell CarcinomaNot listed2025-02-21
QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) TherapyNCT03197584 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Ovarian CancerNot listed2025-02-21
QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRCNCT03169777 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Colorectal CancerNot listed2025-02-21
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsNCT03169738 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Non-small Cell Lung CancerNot listed2025-02-21
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyNCT03175666 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Triple Negative Breast CancerNot listed2025-02-21
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyNCT03197571 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Urothelial CarcinomaNot listed2025-02-21
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 TherapyNCT03167177 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2MelanomaNot listed2025-02-21
QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) VaccineNCT03563170 · ImmunityBio, Inc.WithdrawnPhase 1, Phase 2Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma RecurrentUnited States2021-03-18
DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal CancerNCT00603460 · University of PennsylvaniaWithdrawnPhase 1, Phase 2Ovarian Cancer, Primary Peritoneal CancerUnited States2017-05-02
Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerNCT01227408 · University of Southern CaliforniaWithdrawnPhase 2Breast CancerUnited States2017-05-02
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung CancerNCT00755157 · University Hospital of CreteWithdrawnPhase 2Small Cell Lung CancerGreece2015-10-07
Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple MyelomaNCT02082405 · Case Comprehensive Cancer CenterWithdrawnPhase 2Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple MyelomaNot listed2015-04-24